Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Interaction Between Nitazoxanide and Atazanavir/Ritonavir
NCT05680792Completed
- Sponsor
- Obafemi Awolowo University
- Start
- Sep 2020
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of nitazoxanide in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Obafemi Awolowo University. Primary endpoints: Minimum plasma concentration at Day 5, Maximum plasma concentration at Day 5 and 1 more. Started Sep 2020; status: completed.
02
Drugs
nitazoxanide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05680792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05680792.